Theravance Biopharma, Inc.

NasdaqGM:TBPH 株式レポート

時価総額:US$412.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Theravance Biopharma マネジメント

マネジメント 基準チェック /34

Theravance Biopharma'sの CEO はRick Winninghamで、 Jun2014年に任命され、 の在任期間は 10.92年です。 の年間総報酬は$ 4.32Mで、 24.3%給与と75.7%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の3.97%を直接所有しており、その価値は$ 16.39M 。経営陣と取締役会の平均在任期間はそれぞれ2年と6.3年です。

主要情報

Rick Winningham

最高経営責任者

US$4.3m

報酬総額

CEO給与比率24.3%
CEO在任期間10yrs
CEOの所有権4.0%
経営陣の平均在職期間2yrs
取締役会の平均在任期間6.3yrs

経営陣の近況

Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

May 02
Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

Recent updates

Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

May 02
Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

Some Confidence Is Lacking In Theravance Biopharma, Inc.'s (NASDAQ:TBPH) P/S

Feb 05
Some Confidence Is Lacking In Theravance Biopharma, Inc.'s (NASDAQ:TBPH) P/S

Upgrade: Analysts Just Made A Sizeable Increase To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Forecasts

Nov 11
Upgrade: Analysts Just Made A Sizeable Increase To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Forecasts

Theravance to purchase $95M of ordinary shares

Sep 28

Things Look Grim For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Today's Downgrade

Sep 21
Things Look Grim For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Today's Downgrade

Theravance Biopharma announces $250M capital return program

Sep 19

Theravance Biopharma GAAP EPS of -$0.11, revenue of $11.1M

Aug 04

Theravance: All-Round Failure

Mar 10

Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Just Trimmed Their Revenue Forecasts By 27%

Aug 09
Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Just Trimmed Their Revenue Forecasts By 27%

Theravance Bio stock falls 6% after nezulcitinib flunks mid-stage COVID-19 induced lung injury study

Jun 21

Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Are Reducing Their Forecasts For This Year

May 09
Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Are Reducing Their Forecasts For This Year

Theravance Biopharma EPS misses by $0.16, misses on revenue

May 04

Shareholders May Not Be So Generous With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation And Here's Why

Apr 21
Shareholders May Not Be So Generous With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation And Here's Why

CEO報酬分析

Theravance Biopharma の収益と比較して、Rick Winningham の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$45m

Dec 31 2023US$4mUS$1m

-US$55m

Sep 30 2023n/an/a

-US$61m

Jun 30 2023n/an/a

-US$68m

Mar 31 2023n/an/a

-US$75m

Dec 31 2022US$6mUS$1m

-US$93m

Sep 30 2022n/an/a

-US$136m

Jun 30 2022n/an/a

-US$196m

Mar 31 2022n/an/a

-US$226m

Dec 31 2021US$4mUS$1m

-US$265m

Sep 30 2021n/an/a

-US$266m

Jun 30 2021n/an/a

-US$264m

Mar 31 2021n/an/a

-US$275m

Dec 31 2020US$7mUS$1m

-US$295m

Sep 30 2020n/an/a

-US$285m

Jun 30 2020n/an/a

-US$270m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$6mUS$984k

-US$236m

Sep 30 2019n/an/a

-US$221m

Jun 30 2019n/an/a

-US$222m

Mar 31 2019n/an/a

-US$223m

Dec 31 2018US$3mUS$957k

-US$216m

Sep 30 2018n/an/a

-US$252m

Jun 30 2018n/an/a

-US$260m

Mar 31 2018n/an/a

-US$285m

Dec 31 2017US$2mUS$933k

-US$285m

報酬と市場: Rickの 総報酬 ($USD 4.32M ) は、 US市場 ($USD 2.45M ) の同規模の企業の平均を上回っています。

報酬と収益: Rickの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Rick Winningham (64 yo)

10yrs

在職期間

US$4,318,531

報酬

Mr. Rick E. Winningham, M.B.A., served as Chairman of Retrotope Inc. since February 2021 until January 2022 . He has been Lead Independent Director and Director of Jazz Pharmaceuticals Public Limited Compa...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Rick Winningham
Chairman & CEO10yrsUS$4.32m3.97%
$ 16.4m
Aziz Sawaf
Senior VP & CFO1.4yrsUS$1.39m0.68%
$ 2.8m
Stuart Knight
Senior VP of IT&I and Chief Information Officerno dataデータなしデータなし
Gail Cohen
Vice President of Corporate Communications & Investor Relationsno dataデータなしデータなし
Brett Grimaud
Senior VP2yrsデータなし0.72%
$ 3.0m
Rhonda Farnum
Chief Business Officer and Senior VP of Commercial & Medical Affairs2.5yrsUS$942.81k0.70%
$ 2.9m
Stacy Pryce
Senior VP & Chief Strategy Officer1.8yrsデータなしデータなし
Aine Miller
SVP of Dev.no dataデータなし0.34%
$ 1.4m

2.0yrs

平均在職期間

54.5yo

平均年齢

経験豊富な経営陣: TBPHの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Rick Winningham
Chairman & CEO10.9yrsUS$4.32m3.97%
$ 16.4m
Eran Broshy
Independent Director10yrsUS$205.14k0.14%
$ 593.7k
Deepika Pakianathan
Independent Director3.9yrsUS$207.68k0.098%
$ 402.1k
Dean Mitchell
Lead Independent Director10yrsUS$211.73k0.17%
$ 683.1k
James Kelly
Independent Director1.2yrsUS$43.10kデータなし
Donal O'Connor
Independent Director8.7yrsUS$195.80k0.13%
$ 538.9k
Susannah Gray
Independent Director1.3yrsUS$346.47k0.065%
$ 267.0k
Laurie Smaldone Alsup
Independent Director6.3yrsUS$197.68k0.13%
$ 545.5k
Jeremy Grant
Independent Directorless than a yearUS$168.36k0.046%
$ 189.1k

6.3yrs

平均在職期間

64.5yo

平均年齢

経験豊富なボード: TBPHの 取締役会経験豊富 であると考えられます ( 6.3年の平均在任期間)。